Rapid improvement of severe anorexia nervosa during treatment with ethyl-eicosapentaenoate and micronutrients

European Psychiatry

Volumn 19, Issue 5, 2004, Pages 317-319

  Ayton, Agnes K ^a   Azaz, Amer ^b   Horrobin, David F ^c  

^a London Huntercombe Manor Hospital   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c Laxdale Ltd   (United Kingdom)

Author keywords

Anorexia nervosa; Eicosapentaenoic acid; Micronutrients; Treatment

Indexed keywords

COPPER; ICOSAPENTAENOIC ACID ETHYL ESTER; LAXATIVE; SELENIUM; TRACE ELEMENT; ZINC;

ADOLESCENT; AMENORRHEA; ANAMNESIS; ANOREXIA NERVOSA; ARTICLE; CASE REPORT; CHILD PSYCHIATRY; DIET RESTRICTION; EXERCISE; FAMILY THERAPY; HOSPITAL DISCHARGE; HUMAN; PATIENT EDUCATION; PRIORITY JOURNAL;

ADOLESCENT; ANOREXIA NERVOSA; BODY MASS INDEX; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MICRONUTRIENTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 3342983298     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2004.06.002     Document Type: Article

References (10)

1. Ben Tovim D.I., Walker K., Gilchrist P., Freeman R., Kalucy R., Esterman A. Outcome in patients with eating disorders: a 5-year study. Lancet. 357:2001;1254-1257
2. Connor W.E. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 71:2000;171S-175S
3. Heird W.C. The role of polyunsaturated fatty acids in term and preterm infants and breastfeeding mothers. Pediatric Clin N Am. 48:2001;173-188
4. Holman R.T., Adams C.E., Nelson R.A., Grater S.J., Jaskiewicz J.A., Johnson S.B., et al. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr. 125:1995;901-907
5. Johnson J.G., Cohen P., Kasen S., Brook J.S. Eating disorders during adolescence and the risk for physical and mental disorders during early adulthood. Arch Gen Psychiatry. 59:2002;545-552
6. Nemets B., Stahl Z., Belmaker R.H. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 159:2002;477-479
7. Peet M., Horrobin D.F. A dose ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 59:2002;913-920
8. Puri B.K., Counsell S.J., Richardson A.J., Horrobin D.F. Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry. 59:2002;91-92
9. Ramsay R., Ward A., Treasure J., Russell G.F. Compulsory treatment in anorexia nervosa. Short-term benefits and long-term mortality. Br J Psychiatry. 175:1999;147-153
10. von Meyenfeldt M.F., et al. Weight gain is associated with improved quality of life in patients with cancer cachexia consuming an energy and protein dense, high n-3 fatty acid oral supplement. Proc Am Soc Clin Oncology. 21:2002;385A